Stakeholders’ Views on Early Diagnosis for Alzheimer’s Disease, Clinical Trial Participation and Amyloid PET Disclosure: A Focus Group Study

Overview of attention for article published in Journal of Bioethical Inquiry, March 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

news: 1 news outlet
twitter: 3 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 81 Mendeley

Summary News X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

Centre for Biomedical Ethics and Law, 15 Mar 2019

What are stakeholders' views on early diagnosis of Alzheimer's disease and amyloid PET scan disclosure? Check out latest paper…